As a Sales Account Executive at ImaginAb, Suzanne Bissonnette brings a wealth of experience and expertise to the team. With a background in physiology and an MBA in Pharmaceutical marketing, Suzanne has worked in large and small Pharma and Radiopharmaceutical companies, and most recently her focus was to expand the use of diagnostic and RLT agents in oncology.
With her extensive background and proven track record, Suzanne Bissonnette plays a crucial role in driving sales initiatives at ImaginAb. Her unique perspective, derived from her education and experience in the industry, enables her to understand and address customers’ needs given her pre-clinical and clinical trial experience.
Suzanne is an active supporter of nuclear medicine advances and of theranostics given her role with foundational radioiodine therapy in Thyroid cancer. She views the incorporation of CD8 ImmunoPET™ in clinical trials worldwide as a great decision-making tool for researchers to accelerate the development of novel targeted therapies which will benefit countless patients who need them.
The decision to join the ImaginAb team aligns with her passion for clinical research advancement and to improve patient outcomes and access to therapies around the world. Ultimately, the goal is to ensure that CD8 ImmunoPET™ is accessible and considered a valuable decision-making tool for every I/O clinical trial.
Check out Suzanne’s profile on the Meet our Team page. Reach out to Suzanne by emailing, sbissonnette@imaginab.com
